Skip to main content Dr. Alexander Vladimir Kornienko
- Professor at Chemistry and Biochemistry, College of Science & Engineering
Grants
2026
- Kornienko, Alexander Vladimir (Principal).
Fungal Sphaeropsidin A for Refractory Cancer,
Texas State Office of Innovation,
Texas State University,
$30000.
(Funded: January 2026 - December 2027).
Grant.
2025
- Kornienko, Alexander Vladimir (Principal).
Sphaeropsidin derivatives to combat cancers,
Formosa Plastics,
Private / Foundation / Corporate,
$17000.
(Funded: September 2025 - August 2027).
Grant.
- Kornienko, Alexander Vladimir (Principal).
Photocaged P-gp Inhibitors,
CPRIT,
State,
$250000.
(Submitted: December 12, 2024, Funded: June 1, 2025 - May 31, 2027).
Grant.
- Kornienko, Alexander Vladimir (Co-Principal), Romo, Daniel (Principal).
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies,
NIH,
Federal,
$2250000.
(Submitted: January 2024, Funded: January 2025 - December 2029).
Grant.
2021
- Kornienko, Alexander Vladimir (Principal).
Denise M. Trauth Endowed Presidential Research Professorship,
Texas State University,
Texas State University,
$90000.
(Submitted: 2021, Funded: 2021 - 2024).
Grant.
2020
- Kornienko, Alexander Vladimir (Co-Principal), Percent Contribution: %4.2, Romo, Daniel (Principal), Percent Contribution: %95.8.
Pharmacophore-Directed Retrosynthesis Applied to Bioactive Natural Products Informing Mechanism of Action Studies,
National Institutes of Health,
Federal,
$1422000.
(Submitted: February 5, 2019, Funded: January 1, 2020 - December 31, 2025).
Grant.
2019
- Kornienko, Alexander Vladimir (Principal), Percent Contribution: %75, La Clair, James (Co-Principal), Percent Contribution: %25.
Tandem Discovery of Drug Leads and Targets via Paal-Knorr reaction,
National Institutes of Health,
Federal,
$374000.
(Funded: September 1, 2019 - August 31, 2021).
Grant.
- Kornienko, Alexander Vladimir (Principal), Percent Contribution: %77, Sun, Dandan (Co-Principal), Percent Contribution: %23.
Acid-Sensitive Glioblastoma Prodrugs Derived from Ophiobolin A,
National Institutes of Health,
Federal,
$461764.
(Funded: February 1, 2019 - January 31, 2023).
Grant.
2017
- Du, Liqin (Principal), Percent Contribution: %10, Kornienko, Alexander (Other), Percent Contribution: %5, Houhgton, Peter (Other), Percent Contribution: %1.
Discovery of new differentiation agents for neuroblastoma therapy,
National Institute of Health, NCI, R15, resubmissiom,
Federal,
$461574.
(Funded: August 1, 2017 - July 31, 2020).
Grant.
2014
- Kornienko, Alexander Vladimir (Principal), Romo (Co-Principal), Rhotago=i (Co-Principal).
Mode of Action of the Amaryllidaceae Alkaloid Lycorine-Promising Anticancer Agent,
NIH/NCI/AREA – CA186046-01A1,
$475518.
(Funded: July 15, 2014 - June 30, 2017).
Grant.
